IP Library Granted Patent US 11,986,555
Granted Patent B2
US 11,986,555 · App. 17/678,178 · Granted May 21, 2024

Chewable pharmaceutical product for delivery of colesevelam hydrochloride

Inventor: Tommy L. Chau (Ashburn, VA)
Assignee: COSETTE PHARMACEUTICALS, INC.
A61K9/0056A61K9/145A61K31/785A61P3/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,986,555
App. No.
17/678,178
Granted
May 21, 2024
Kind
B2
Abstract

A chewable pharmaceutical product comprises a matrix comprising: a binder, a bulking agent, a lubricant, a humectant, an emulsifier, and optionally a flavoring, wherein the binder comprises one or more maltitol syrups, which are present in the pharmaceutical product in an amount in the range of 60-70% by weight; and colesevelam hydrochloride.

Claims (33)

1. A method of making a chewable pharmaceutical product for delivery of colesevelam hydrochloride comprising:

(ix) heating an amount of one or more maltitol syrups to a temperature of in the range of 120-160° F.;

(x) melting a lubricant;

(xi) blending dry ingredients in a mixer, the dry ingredients comprising: at least colesevelam hydrochloride and a bulking agent;

(xii) adding the one or more maltitol syrups, the lubricant, a humectant, and an emulsifier to the dry ingredients in the mixer;

(xiii) optionally adding one or more of a flavoring, coloring, and an antioxidant to the mixture;

(xiv) mixing all of the ingredients until substantially uniform to form an active-ingredient-containing matrix;

(xv) extruding the active-ingredient-containing matrix and then cutting to form the chewable pharmaceutical product,

wherein the amount of the one or more maltitol syrups in the chewable pharmaceutical product is in the range of 60-70% by weight;

(xvi) packaging the chewable pharmaceutical product,

wherein the one or more maltitol syrups comprise two maltitol syrups: a first maltitol syrup having a higher solids content than a second maltitol syrup, which are present in a weight ratio (first maltitol syrup:second maltitol syrup) of from 2:1 to 4:1, which in combination, have an effective solids content in the range of 81.5-83.3%.

2. The method of claim 1 , wherein extruding occurs at a temperature of 40° C.±10° C.

3. The method of claim 1 , wherein the pharmaceutical product comprises by weight of the pharmaceutical product:

(a) colesevelam hydrochloride in an amount of 3.75 grams±10%;

(b) maltitol syrup as the binder in an amount in the range of 63-66%;

(c) one or more of: maltodextrin and gum acacia as the bulking agent totaling an amount in the range of 5-15%;

(d) palm oil as the lubricant in an amount in the range of 1.5-6%;

(e) glycerin as the humectant in an amount in the range of 1-3%;

(f) lecithin as the emulsifier in an amount in the range of 1-2%;

(g) a flavoring in an amount in the range of 0.01-6%; and

(h) optionally one or more of a powdered sweetener, a coloring, and an antioxidant;

wherein ingredients (a)-(h) total 100%.

4. The method of claim 1 , wherein the pharmaceutical product comprises by weight of the pharmaceutical product:

(a) colesevelam hydrochloride in an amount of 12.5%;

(b) maltitol solids in an amount in the range of 52-54%;

(c) one or more of: maltodextrin and gum acacia as the bulking agent totaling an amount in the range of 5-15%;

(d) palm oil as the lubricant in an amount in the range of 1.5-6%;

(e) glycerin as the humectant in an amount in the range of 1-3%;

(f) lecithin as the emulsifier in an amount in the range of 1-2%;

(g) a flavoring in an amount in the range of 0.01-6%;

(h) water in an amount in the range of 11.5-12.5% and

(i) optionally one or more of a powdered sweetener, a coloring, and an antioxidant;

wherein ingredients (a)-(i) total 100%.

Assignments (6)
PATENT SECURITY AGREEMENT Recorded Jul 9, 2024
From: COSETTE PHARMACEUTICALS, INC.
To: UBS AG, STAMFORD BRANCH, AS ADMINISTRATIVE AGENT
Reel/Frame 068257/0824 →
SECURITY INTEREST Recorded Jun 26, 2024
From: COSETTE PHARMACEUTICALS, INC.; MYRIEL PHARMACEUTICALS, LLC
To: HAYFIN SERVICES LLP, AS ADMINISTRATIVE AGENT
Reel/Frame 067849/0095 →
PATENT SECURITY AGREEMENT Recorded Apr 26, 2023
From: COSETTE PHARMACEUTICALS, INC.
To: WELLS FARGO BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 063470/0372 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 24, 2022
From: CHAU, TOMMY L.
To: NUTRAVAIL LLC
Reel/Frame 059084/0878 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 24, 2022
From: NUTRAVAIL LLC
To: DAIICHI SANKYO, INC.
Reel/Frame 059084/0950 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 24, 2022
From: DAIICHI SANKYO, INC.
To: COSETTE PHARMACEUTICALS, INC.
Reel/Frame 059085/0025 →
Continuity (2)
Division 15215804 · Jul 21, 2016
Related Publication 20220175669A1 · Jun 9, 2022